Hyperbaric oxygen therapy shows promise as a treatment for Alzheimer’s disease

Paapa Mensah Kane
Paapa Mensah-Kane

New findings by a team of researchers at The University of North Texas Health Science Center at Fort Worth’s School of Biomedical Sciences are expanding people’s understanding of the potential benefits of hyperbaric oxygen therapy as a treatment for Alzheimer’s disease. 

Their study, titled “Hyperbaric Oxygen Alleviates Selective Domains of Cognitive and Motor Deficits in Female 5XFAD Mice,” was published recently in GeroScience, a leading international journal focused on the biology of aging and the pathophysiology of age-related diseases. 

“What we see in our research is that hyperbaric oxygen therapy leads to cognitive improvements in Alzheimer’s disease mouse models and that these improvements were more pronounced in females than in males,” said Paapa Mensah-Kane, PhD candidate in the lab of Dr. Nathalie Sumien and first author of the study.   

“We are very excited about the results.” 

Hyperbaric oxygen therapy, which includes breathing pure oxygen in a pressurized environment, has been used for decades to treat health problems like decompression sickness and severe infections. It has also emerged as a potential option for managing the effects of Alzheimer’s. 

After applying hyperbaric oxygen therapy to the Alzheimer’s model, the team tested for different cognitive domains like memory and associative learning. They also evaluated the effects on motor deficits and explored how the therapy affected males and females differently.   

“The good thing about exploring hyperbaric oxygen therapy is that we don’t have to try to create a new research model, we just have to repurpose it for Alzheimer’s, a disease that has been a menace to mankind,” Mensah-Kane said. 

Sumien says these results could open the door for exploring other benefits of hyperbaric oxygen therapy. 

“These findings reveal promising insights into a potential therapy not only for Alzheimer’s Disease, but also for other conditions affecting brain function,” said Sumien, who serves as interim chair and professor of pharmacology and neuroscience at HSC.  

With 6.2 million American’s living with Alzheimer’s disease, Mensah-Kane says there is a critical need to continue research that explores new treatments for the debilitating neurodegenerative disorder. 

“As a PhD student, I have been deeply inspired by the quest for solutions to complex challenges. The inspiration to explore hyperbaric oxygen on Alzheimer’s disease stems from a profound desire to contribute meaningfully to the field of neuroscience,” Mensah-Kane said.  

“Witnessing the devastating impact of Alzheimer’s has fueled my commitment to explore innovative approaches. These results are not just about scientific advancement, but a celebration of persistence and collective effort of a dedicated team.” 

Mensah-Kane completed the research as part of his PhD in Biomedical Sciences degree in the School of Biomedical Sciences at HSC. He plans to continue and expand his research on hyperbaric oxygen therapy for Alzheimer’s disease.  

The research team also includes Dr. Delaney Davis, Helen Shi, Oanh Trinh, Philip Vann and Dr. Ladislav Dory.  

Read the study: Hyperbaric Oxygen Alleviates Selective Domains of Cognitive and Motor Deficits in Female 5XFAD Mice 

Recent News

Uyen Sa Nguyen Scaled[58]
  • Our People
|Apr 12, 2024

Faculty Highlight: Dr. Uyen-Sa D. T. Nguyen

Dr. Nguyen is an associate professor, population and community health, at The University of North Texas Health Science Center’s School of Public Health. She recently received a new pilot grant and donation from an HSC Foundation donor to support her research. Here, she talks about this new funding...
Pain Registry Licciardone
  • Research
|Apr 11, 2024

JAMA Network publishes HSC study showing chronic pain favorable outcomes associated with physician empathy

JAMA Network Open this month published an article, “Physician Empathy and Chronic Pain Outcomes,” based on national data collected by the Pain Registry for Epidemiological, Clinical, and Interventional Studies and Innovation (PRECISION) at The University of North Texas Health Science Center at F...
Cbc 6723 Scaled
  • Community
|Apr 11, 2024

A selfless act with a significant impact

In the United States alone, a patient receives a blood transfusion every two seconds. The average transfusion patient receives 2.5 units of blood — approximately 200 milliliters of red blood cells. Every three minutes, someone is diagnosed with a blood cancer, like lymphoma or leukemia, that r...
Public Health Week Preferred First Student Pic Img 6651 (1)
  • Our People
|Apr 10, 2024

National Public Health Week focuses on community: protecting, connecting, thriving

National Public Health Week is a time each year to celebrate the essential services of public health professionals who work tirelessly to promote their communities’ health, safety and well-being. National Public Health Week is held each April, and is sponsored by the American Public Health Associa...